Mario Martinotti

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

Giovanni Allevi, Carla Strina, Daniele Andreis et al. · British Journal of Cancer · 2013 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study

Umberto Bracale, Mauro Podda, Simone Castiglioni et al. · Updates in Surgery · 2021 · 41 citations · Full text

Medicine, Infectious Diseases, Surgery +14

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment

Daniele Generali, Francesca M. Buffa, Siddhartha Deb et al. · British Journal of Cancer · 2014 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer

Letizia Bazzola, Chiara Foroni, Daniele Andreis et al. · British Journal of Cancer · 2014 · 30 citations · Full text

Medicine, Oncology, Pharmacology +16

Compliance to Adjuvant Chemotherapy of Patients Who Underwent Surgery for Rectal Cancer: Report from a Multi‐institutional Research Network

Giulio Mari, Dario Maggioni, Jacopo Crippa et al. · World Journal of Surgery · 2019 · 26 citations

Medicine, Oncology, Surgery +11